Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Research and Markets: Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Pipeline Review, H1 2015 - 24 Companies & 15 Drug Profiles

share with twitter share with LinkedIn share with facebook
share via e-mail
07/09/2015 | 03:48pm CEST

Research and Markets (http://www.researchandmarkets.com/research/g4d563/ankylosing) has announced the addition of the "Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Amgen Inc.
  • Avesthagen Limited
  • Biocon Limited
  • Boehringer Ingelheim GmbH
  • Celgene Corporation
  • Celltrion, Inc.
  • Covagen AG
  • Epirus Biopharmaceuticals, Inc.
  • Genor BioPharma Co., Ltd.
  • Inbiopro Solutions Pvt. Ltd.
  • Innovent Biologics, Inc.
  • Johnson & Johnson
  • Lupin Limited
  • Mabion SA
  • Momenta Pharmaceuticals, Inc.
  • Novartis AG
  • Oncobiologics, Inc.
  • Panacea Biotec Limited
  • Pfizer Inc.
  • Protalix BioTherapeutics, Inc.
  • Sandoz International GmbH
  • Shanghai Pharmaceutical Co., Ltd.
  • Therapeutic Proteins International, LLC

Drug Profiles

  • adalimumab biosimilar
  • apremilast
  • BI-655066
  • COVA-322
  • etanercept biosimilar
  • golimumab
  • golimumab biosimilar
  • IBI-303
  • IBPM-004AM
  • IBPM-005IX
  • infliximab biosimilar
  • INV-17
  • secukinumab
  • thalidomide
  • tofacitinib

For more information visit http://www.researchandmarkets.com/research/g4d563/ankylosing

© Business Wire 2015
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news "Companies"
10:25pNATIONAL SECURITY : African Press Review 20 July 2018
10:25pPETMED EXPRESS INC : Other Events (form 8-K)
10:25pJ C PENNEY CO INC : Change in Directors or Principal Officers (form 8-K)
10:25pFINCANTIERI : starts work in Genoa on second Virgin Voyages ship
10:25pPFIZER : U.S. FDA Approves Pfizer’s Biosimilar NIVESTYM™ (filgrastim-aafi)
10:24pROCKWELL AUTOMATION INC : Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (form 8-K)
10:24pFNCB BANCORP, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
10:24pVENATOR MATERIALS : Submission of Matters to a Vote of Security Holders (form 8-K/A)
10:23pHARVEST GOLD : Sells its Suriname Properties
10:23pUSG CORP : Change in Directors or Principal Officers, Other Events (form 8-K)
Latest news "Companies"